Is the metabolic syndrome, with or without diabetes, associated with progressive disability in older Mexican Americans?

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 62, Issue 7, 2007, Pages 766-773

  Blaum, Caroline S ^a   West, Nancy A ^b   Haan, Mary N ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ELDERLY CARE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL DISABILITY; PRIORITY JOURNAL; SCORING SYSTEM; STRENGTH; WALKING DIFFICULTY; BODY MASS; DISABLED PERSON; HISPANIC; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DISABLED PERSONS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MEXICAN AMERICANS; MIDDLE AGED;

EID: 34548384331     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/62.7.766     Document Type: Article

References (41)

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
2. Lawlor DA, Ebrahim S, Davey Smith G. The metabolic syndrome and coronary heart disease in older women: findings from the British Women's Heart and Health Study. Diabet Med. 2004;21: 906-913.
3. Centers for Disease Control and Prevention (CDC). Diabetes among Hispanics-Los Angeles, California, 2002-2003. MMWR Morb Mortal Wkly Rep. 2003;52:1152-1155.
4. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adults Treatment Panel III). JAMA. 2001;285:2486-2497.
5. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289-2304.
6. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006;83:1237-1247.
7. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91:2906-2912.
8. Hanley AJ, Festa A, D'Agostino RB Jr, et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes. 2004;53:1773-1781.
9. Grundy SM. Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr. 2006;83:1248-1251.
10. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164:1066-1076.
11. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
12. Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D'Agostino RB, Wolf PA. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med. 2006;166:106-111.
13. Maggi S, Noale M, Gallina P, et al. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. J Gerontol Biol Sci Med Sci. 2006; 61A:505-510.
14. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs. Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005; 165:2644-2650.
15. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066-3072.
16. Gardner AW, Montgomery PS, Parker DE. Metabolic syndrome impairs physical function, health-related quality of life, and peripheral circulation in patients with intermittent claudication. J Vasc Surg. 2006; 43:1191-1196; discussion 1197.
17. Gregg EW, Beckles GL, Williamson DF, et al. Diabetes and physical disability among older U.S. adults. Diabetes Care. 2000;23:1272-1277.
18. Volpato S, Blaum C, Resnick H, Ferrucci L, Fried LP, Guralnik JM. Comorbidities and impairments explaining the association between diabetes and lower extremity disability: the Women's Health and Aging Study. Diabetes Care. 2002;25:678-683.
19. Volpato S, Ferrucci L, Blaum C, et al. Progression of lower-extremity disability in older women with diabetes: the Women's Health and Aging Study. Diabetes Care. 2003;26:70-75.
20. Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH. Diabetes as a predictor of change in functional status among older Mexican Americans: a population-based cohort study. Diabetes Care. 2003;26:314-319.
21. Lorenzo C, Williams K, Hunt KJ, Haffner SM. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Diabetes Care. 2006;29: 625-630.
22. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffher SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:2160-2167.
23. Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ. Prevalence of dementia in older Latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc. 2003;51:169-177.
24. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement. 1977;1: 385-401.
25. Byers AL, Allore H, Gill TM, Peduzzi PN. Application of negative binomial modeling for discrete outcomes: a case study in aging research. J Clin Epidemiol. 2003;56:559-564.
26. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
27. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodol. 2001;27: 85-95.
28. Raghunathan TE, Solenberger PW, VanHoewyk J. IVEware: Imputation and Variance Estimation Software. 1998. Ann Arbor, MI: University of Michigan institute for Social Research.
29. Little RJ, Schenker N. Missing data. In: Arminger G, Clogg CC, Sobel ME, eds. Handbook of Statistical Modeling for the Social and Behavioral Sciences. New York: Plenum Press; 1995:39-68.
30. SAS/STAT User's Guide Version 8. Cary, NC: The SAS Institute; 2001.
31. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. WHO Obesity Technical Report Series no. 894, Geneva, Switzerland: WHO; 2000.
32. Pope A, Tarlov A, Committee on a National Agenda for the Prevention of Disabilities, Division of Health Promotion and Disease Prevention, Institute of Medicine, eds. Disability in America: Toward a National Agenda for Prevention. Washington, DC: The National Academies Press; 1991.
33. Visser M, Langlois J, Guralnik JM, et al. High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr. 1998;68:584-590.
34. Hu G, Lindstrom J, Valle TT, et al. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med. 2004;164:892-896.
35. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
36. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
37. Haffner SM, Mykkanen L, Festa A, Burke JP, Stem MP. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation. 2000;101:975-980.
38. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes. 2004;53:1195-1200.
39. Haffner SM. Epidemiology of insulin resistance and its relation to coronary artery disease. Am J Cardiol. 1999;84:11J-14J.
40. Krebs M, Roden M. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes Obes Metab. 2005;7:621-632.
41. McNeill AM, Rosamond WD, Girman CJ, et al. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol. 2004;94:1249-1254.